Drug Database
IG

IG-RD-001 (Tesalin / Ze 339 / Ze339)

✓ Approved

China Medical System · 治疗药物

什么是 IG-RD-001?

IG-RD-001 是一种治疗药物,由China Medical System研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Tesalin, Ze 339, Ze339
公司China Medical System
给药途径Oral (PO)
状态Approved

治疗适应症

IG-RD-001 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Respiratory, thoracic and mediastinal disordersRhinitis allergic✓ Approved

相关研究文献

PubMedInternational journal of rheumatic diseases2026-11-17

A Gap on Judgment of Fertility and the Need for Contraception Between Physicians and Patients With Rheumatic Diseases: A Multicenter Questionnaire Survey.

Moriyama Mayuko M, Murakawa Yohko Y, Nagafuchi Hiroko H, Shirota Yuko Y et al.

Effective contraception is essential for women of reproductive age with rheumatic disease (RD), specifically those receiving teratogenic drugs, and physicians should recognize that these women may wish to conceive or control their fertility. This study aimed to evaluate the status of preconception care and contraception use, awareness, and counseling among women with RD in Japan. This cross-sectional questionnaire survey included Japanese women with RD (age: 18-45 years) and their attending physicians, conducted between September 2023 and May 2024 at 14 medical institutions. Patient and physician responses were linked and analyzed. In total, 157 patients completed the survey. Of these, 35% of patients wished to conceive in the future and 38% were aware of their current need for contraception. The results revealed a gap between physicians' and patients' judgment of fertility and the need for contraception. Most patients used less effective contraceptive methods (condoms: 67.1%; withdrawal: 20.5%). Although patients were aware of the need for contraception, only 12% had received specific contraception instructions from their healthcare providers, whereas 39% had never received contraception counseling. Most of the patients decided on contraceptive methods themselves or together with their partners. One patient who tested positive for antiphospholipid antibodies used contraindicated estrogen-containing contraceptives. Significant deficiencies exist in contraception counseling and awareness among women with RD. Proactive and system-building approaches are urgently required to improve preconception care and reproductive safety in this population.

PMID 43040972
阅读全文 →
PubMedOrthopedics2026-11-17

Surgical Site Infection After Posterolateral Lumbar Fusion: Incidence and Risk Factors in a Nationwide Database.

Mastrokostas Paul G PG, Schwartz Luke B LB, Said Mohamed M, Mastrokostas Leonidas E LE et al.

Posterolateral lumbar fusion (PLF) is a widely performed procedure for degenerative lumbar spine disease, yet postoperative surgical site infection (SSI) remains a consequential complication. The aim of this study was to estimate the national 90-day incidence of SSI following PLF and identify independent predictors of 90-day SSI. We performed a retrospective cohort study of adults undergoing PLF in the PearlDiver Mariner database from 2016 to 2023. Multivariable logistic regression identified independent predictors of 90-day SSI, adjusting for demographic, procedural, and comorbidity variables. Significance was set at P < .001. Among 291,435 PLF procedures, 14,725 (5.1%) developed a 90-day SSI. SSI occurred in 4.0% (6,105/151,951) of single-level PLF cases and 6.2% (8,620/139,484) of multilevel cases. Multilevel fusion significantly increased infection risk compared with single-level PLF (odds ratio [OR] 1.47, P < .001). Independent predictors included obesity (OR 1.60, P < .001), anemia (OR 1.70, P < .001), fluid and electrolyte disorders (OR 1.59, P < .001), essential hypertension (OR 1.34, P < .001), congestive heart failure (OR 1.22, P < .001), depression (OR 1.21, P < .001), diabetes (OR 1.15, P < .001), cardiac arrhythmias (OR 1.21, P < .001), coagulopathy/hemorrhagic disorders (OR 1.18, P < .001), substance-related disorders (OR 1.18, P < .001), peripheral vascular disease (OR 1.17, P < .001), and tobacco use (OR 1.11, P < .001). Ninety-day SSI after PLF was more frequent following multilevel fusion and among patients with substantial cardiometabolic, hematologic, and behavioral comorbidities.

PMID 43042939
阅读全文 →
PubMedCJC open2026-11-17

Diagnostic Performance and Clinical Outcomes of Coronary Computed Tomography Angiography Before Valve Surgery: A Systematic Review and Meta-analysis.

Sun Calvin C, Qian Yu Chen YC, Wilson Emma E, Rezaee Arad A et al.

Recently published guidelines recommend coronary computed tomography angiography (CCTA) instead of invasive coronary angiography (ICA) for preoperative coronary evaluation in valve surgery patients with a low to moderate risk of coronary artery disease (CAD). However, evidence supporting the use of CCTA as a first-line preoperative coronary assessment strategy in this population remains uncertain. We performed a systematic review and meta-analysis comparing diagnostic performance and clinical outcomes of CCTA vs ICA. We searched 5 databases through October 2025 for studies comparing preoperative CCTA with ICA in valve surgery patients reporting diagnostic accuracy and/or clinical outcomes. Pooled estimates were calculated. Coprimary outcomes were per-patient diagnostic accuracy and late major adverse cardiovascular events (MACE). Sixteen observational studies were included (5781 total patients). Pooled sensitivity and specificity of CCTA relative to ICA were 86% (95% confidence interval [CI] 0.78-0.91) and 87% (95% CI 0.81-0.91), respectively (area under the curve = 0.93). There was no difference in concomitant coronary artery bypass graft (CABG) (risk difference [RD] -0.10, 95% CI -0.36 to 0.17, P = 0.32) and unplanned CABG (RD -0.00, 95% CI -0.01 to 0.01, P = 0.76) rates between CCTA and ICA. In-hospital/30-day outcomes were similar, including mortality (OR 1.07, 95% CI 0.42-2.70, P = 0.79), myocardial infarction (odds ratio [OR] 0.90, 95% CI 0.11-7.21, P = 0.63), stroke (OR 1.41, 95% CI 0.01-286.87, P = 0.56), acute kidney injury (OR 1.07, 95% CI 0.90-1.26, P = 0.25), and revascularization (RD -0.00, 95% CI -0.00 to 0.00, P = 0.26). Late MACE did not differ (incidence rate ratio 1.16, 95% CI 0.15-8.96, P = 0.52, median follow-up 31.7 months). CCTA may serve as a reasonable rule-out strategy for CAD in appropriately selected elective valve surgery patients. Although no significant differences in clinical outcomes were observed compared with ICA, larger contemporary prospective studies are required.

PMID 43042241
阅读全文 →
PubMedPakistan journal of medical sciences2026-11-17

Frequency of Non-GI Prescriptions of Proton Pump Inhibitors from Academic and Non-Academic Hospitals.

Ali Faiza Sadaqat FS, Zuberi Bader Faiyaz BF, Rasheed Tazeen T, Zuberi Faisal Faiyaz FF

To determine the frequency of non-GI proton pump inhibitor (PPI) prescriptions at discharge and compare prescribing patterns between academic and non-academic hospitals. This cross-sectional study included 768 patients receiving PPI prescriptions from two academic and two non-academic hospitals in Karachi from July 2023 to July 2024. Prescriptions were reviewed against published PPI-use guidelines. Categorical variables were compared using the chi-square test, and regression analysis was used to identify predictors of prescription appropriateness. Among 768 patients, 384 were from academic and 384 from non-academic hospitals. Overall, 364 (47.4%) PPI prescriptions were for non-GI indications. Non-GI prescriptions were 45.83% in academic hospitals and 48.96% in non-academic hospitals, with no significant difference between groups (p = .386). The multiple regression model was statistically significant, F(13, 754) = 203.23, p < .001, explaining 77.8% of the variance in prescription appropriateness (R2 = .778, adjusted R2 = .774). Gastrointestinal ulcer bleeding prophylaxis (β = .460, p < .001), treatment of symptomatic GERD (β = .357, p < .001), chest pain with negative cardiac and pulmonary work-up suspected to be due to dyspepsia or GERD (β = .277, p < .001), and treatment of NSAID-induced gastric ulcers (β = .268, p < .001) were the strongest clinical predictors. Non-GI PPI prescriptions were frequent in both hospital types. Prescription appropriateness was associated with clinical, institutional, and departmental factors, supporting regular prescription review, physician education, and guideline-based PPI stewardship.

PMID 43042120
阅读全文 →
PubMedRadiology2026-11-17

Temporal Trends in High-Risk Benign Breast Disease Detection at Screening Mammography: Results from the Breast Cancer Surveillance Consortium.

Sprague Brian L BL, Ponzini Matthew M, Sattayapiwat Olivia O, Eliassen M Scottie MS et al.

Background Nationally representative data comparing high-risk benign breast disease (BBD) detection with digital breast tomosynthesis (DBT) versus digital mammography are lacking. Purpose To describe temporal trends in high-risk BBD detection rates at screening mammography in the Breast Cancer Surveillance Consortium (BCSC) over nearly 2 decades and to evaluate the association between mammographic modality and high-risk BBD detection. Materials and Methods In this retrospective cohort study using prospectively collected data from the BCSC, screening mammograms obtained from 2005 to 2022 among women aged 40 to 79 years at 97 health care facilities were analyzed; examinations in women with prior breast cancer or mastectomy were excluded. Regression analyses were used to estimate annual percent change (APC) in detection rates, and multivariable logistic regression was used to estimate adjusted odds ratios (ORs) according to mammographic modality. Results A total of 4 469 664 screening mammograms in 1 190 380 women (mean age, 57.3 years ± 10.1 [SD]) were included. The overall high-risk BBD detection rate was 1.11 per 1000 examinations, with no evidence of a temporal trend since 2017 (APC = 5.3% [95% CI: -1.1, 21.9]; P = .09). Atypical ductal hyperplasia detection declined from 2009 to 2017 (APC = -7.4% [95% CI: -12.0, -5.4]; P < .001). Detection of radial sclerosing lesions (APC = 5.4% [95% CI: 3.5, 7.8]; P < .001) and atypical papillary lesions (APC = 19.0% [95% CI: 14.8, 25.1]; P < .001) increased from 2005 to 2022. Compared with digital mammography, DBT was associated with increased detection of high-risk BBD overall (OR = 1.36 [95% CI: 1.24, 1.49]; P < .001), lobular carcinoma in situ (OR = 1.37 [95% CI: 1.02, 1.85]; P = .04), atypical lobular hyperplasia (OR = 1.45 [95% CI: 1.19, 1.77]; P < .001), and radial sclerosing lesions (OR = 2.64 [95% CI: 2.15, 3.23]; P < .001). Conclusion Over the past 2 decades, detection of atypical papillary lesions and radial sclerosing lesions increased, whereas detection of atypical ductal hyperplasia declined. DBT was associated with increased detection of high-risk BBD, including lobular carcinoma in situ, atypical lobular hyperplasia, and radial sclerosing lesions. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Hooley in this issue.

PMID 43043180
阅读全文 →
PubMedJournal of pathology and translational medicine2026-11-17

A demographic study of pathology-proven kidney tumors at a single institution in South Korea over the past 33 years: 1991-2023.

Kim Seon Ung SU, Noh Hyejin H, Kim Jiyeon J, Choi Yeong Jin YJ

While the incidence of kidney tumors is increasing, long-term demographic analyses based on pathological diagnoses remain insufficient. This study aimed to investigate demographic changes regarding pathology-proven kidney tumors over the past 33 years. We retrospectively analyzed 4,555 cases from 4,350 patients who underwent renal biopsy or nephrectomy for suspected kidney tumors at Seoul St. Mary's Hospital from 1991 to 2023. The average age was 58 years, and the male-to-female ratio was 1.7:1. Among 4,555 cases, 7.0% were biopsies and 93.0% were nephrectomies. Tumors were classified into four diagnostic categories: malignant (79.3%), benign (18.5%), undefined (1.5%), and other lesions (0.7%). Over 33 years, biopsies increased 14.3-fold and nephrectomies 11.5-fold, while malignant tumors increased 12.6-fold and benign tumors 9.4-fold. Over time, the proportion of malignant tumors increased (p < .001), while benign tumors decreased (p < .001). As age increased, the proportion of malignant tumors increased (p = .013), while benign tumors showed a decreasing trend (p = .070). Malignant tumors showed a male predominance, while benign tumors showed a female predominance. The frequency of malignant tumors was similar at approximately 80% in biopsy and nephrectomy. However, benign tumors were more common in nephrectomy (19.1%) than in biopsy (10.9%) (p < .001), and unclassified tumors (4.1%) were more common in biopsies (p < .001). Renal cell carcinoma was most common (61.5% of total cases, 77.6% of malignant tumors). Lymphoproliferative tumors were diagnosed more frequently by biopsy (12.5%) than nephrectomy (0.1%) (p < .001). This study demonstrates a long-term increase in the incidence of renal tumors in South Korea. These findings can serve as foundational data for patients with kidney tumors.

PMID 43040994
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多IG-RD-001